[Regulator75]

http://www.iflscience.com/health-and...-loss-3-months

Turing Pharmaceuticals has reported a $14.6 million net loss in their third-quarter, from July to the end of September, this year.

In mid-August, the pharmaceutical company purchased the rights of Daraprim and raised the price by over 5,000 percent, making the cost of the pill rocket from $13.50 (£8.70) a tablet to $750 (£485). The drug is used by patients with AIDS or cancer to fight the Toxoplasma gondii parasite. More than 60 million Americans carry the parasite without coming to harm, but it can lead to seizures, blindness or neurological damage to those with a compromised immune system.